Wasatch Advisors Inc Sangamo Therapeutics, Inc Transaction History
Wasatch Advisors Inc
- $20.1 Billion
- Q3 2024
A detailed history of Wasatch Advisors Inc transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Wasatch Advisors Inc holds 19,442,368 shares of SGMO stock, worth $36.9 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
19,442,368
Previous 20,090,570
3.23%
Holding current value
$36.9 Million
Previous $7.23 Million
131.19%
% of portfolio
0.08%
Previous 0.04%
Shares
30 transactions
Others Institutions Holding SGMO
# of Institutions
114Shares Held
56.3MCall Options Held
576KPut Options Held
1.17M-
Vanguard Group Inc Valley Forge, PA9.6MShares$18.2 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.85MShares$9.22 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.7MShares$8.94 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.35MShares$4.47 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.14MShares$4.06 Million0.0% of portfolio
About SANGAMO THERAPEUTICS, INC
- Ticker SGMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 156,552,992
- Market Cap $297M
- Description
- Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...